711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I

Mitoxantrone hydrochloride liposome injection combined with thiotepa-busulfan-fludarabine (MTBF) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation for central nervous system leukemia

Ciltacabtagene autoleucel out of specification manufacturing outcomes improve with earlier lines of therapy

Development of multi targeting CAR double negative T cells for allogeneic immunotherapy in B cell leukemia

Varnimcabtagene autoleucel in relapsed refractory B cell malignancies Manufacturing experience from India

Clinical study on the efficacy and safety of pegylated recombinant human granulocyte colony stimulating factor injection PEG rhG CSF in autologous hematopoietic stem cell mobilization for lymphoma Results of interim analysis

Results of the first Latin American point of care manufactured Phase I anti CD19 CAR T study CARTHIAE for Relapsed Refractory B cell neoplasms

Optimizing the manufacturing and delivery of LV20 19 CAR T cells for relapsed refractory DLBCL and FL